Skip to main content

5 articles related to "Lapatinib Resistance"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 01 Apr 2022

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

in Experimental Pharmacology and Drug Discovery

Hongmei Dong
Liang Du
Songwang Cai
Wan Lin
Chaoying Chen
Matthew Still
Zhimeng Yao
Robert P. Coppes
Yunlong Pan
Dianzheng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.838171

4,576 views
8 citations

Original Research

Published on 29 Jun 2021

Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2

in Pharmacology of Anti-Cancer Drugs

Bo-Wei Wang
Chih-Hao Huang
Liang-Chih Liu
Fang-Ju Cheng
Ya-Ling Wei
Yueh-Ming Lin
Yu-Fei Wang
Ching-Ting Wei
Yeh Chen
Yun-Ju Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.614673

6,545 views
11 citations

Original Research

Published on 06 Jul 2021

Circular RNA circ-MMP11 Contributes to Lapatinib Resistance of Breast Cancer Cells by Regulating the miR-153-3p/ANLN Axis

in Molecular and Cellular Oncology

Xiaoli Wu
Yi Ren
Rong Yao
Leilei Zhou
Ruihua Fan

Frontiers in Oncology

doi 10.3389/fonc.2021.639961

6,362 views
56 citations

Original Research

Published on 05 Jul 2021

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Min Ye
Wei Huang
Rui Liu
Yingli Kong
Yang Liu
Xiaole Chen
Jianhua Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.651516

5,317 views
16 citations

Original Research

Published on 23 Jan 2019

Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells

in Head and Neck Cancer

Christine E. Lehman
Rolando E. Mendez
Michael I. Dougherty
Amir Allak
Oluwayemisi L. Adejumo
Linnea E. Taniguchi
Ashraf Khalil
Daniel G. Gioeli
Mark J. Jameson

Frontiers in Oncology

doi 10.3389/fonc.2019.00013

3,487 views
7 citations